Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01369758 · ClinicalTrials.gov registry record · NA

MyoSure Hysteroscopic Tissue Removal System Registry Study

A NA study, sponsored by Hologic.

Completed
Registry status
NA
Development phase
290
Enrollment target

NCT01369758: Completed NA study, sponsored by Hologic.

NCT01369758 is a NA study that has completed, run by Hologic. The registered enrollment target is 290 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01369758, a NA study, has completed, sponsored by Hologic.

COMPLETED
Registry status
NA
Development phase
290 participants
Enrollment target

Study Summary

The objective of this study is to demonstrate the safety and effectiveness of community gynecologist initiated treatment of intra-uterine polyps and submucosal fibroids with the MyoSure Hysteroscopic Tissue Removal System in a significantly sized patient population.

Primary Outcome

Mean percent of pathology removed, based on hysteroscopic assessment immediately following completion of the treatment procedure

Interventions

  • DEVICE MyoSure Tissue Removal System

Trial Details

FieldValue
Enrollment Target 290 participants
Start Date 2010-11
Est. Completion 2013-05
Phase NA
Hologic

21 total trials

What the finished NCT01369758 record still lists

NCT01369758 is an interventional study that assigns participants to a tested intervention. The registered 290 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).

The record links to 0 conditions, and to 1 intervention - of which MyoSure Tissue Removal System is the first listed.

NCT01369758 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01369758 about?

NCT01369758 is a clinical study titled "MyoSure Hysteroscopic Tissue Removal System Registry Study". The objective of this study is to demonstrate the safety and effectiveness of community gynecologist initiated treatment of intra-uterine polyps and submucosal fibroids with the MyoSure Hysteroscopic Tissue Removal System in a significantly sized patient population.

What is the current status of trial NCT01369758?

This trial is currently completed. It is a NA study. The enrollment target is 290 participants. The study started on 2010-11. Estimated completion is 2013-05.

What interventions are being tested in trial NCT01369758?

The interventions under investigation include: MyoSure Tissue Removal System (DEVICE).

Who is sponsoring clinical trial NCT01369758?

This trial is sponsored by Hologic, which has 21 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01369758's enrollment target sits among peer trials

290 375th of 2000 higher than 1,625 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00775476 · 290 participants · Phase 2

    Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine

  • NCT01874197 · 290 participants · NA

    Branched Thoracic Endovascular Grafts for the Treatment of Thoraco-abdominal Aortic

  • NCT04331353 · 290 participants · NA

    The Allergen Reduction and Child Health Study (ARCHS)

  • NCT04649008 · 290 participants · Early Phase 1

    Localizing Epileptic Networks Using MRI and iEEG

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01369758, the US trial registry maintained by the National Library of Medicine. NCT01369758 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.